Skip to main content

Table 2 Characteristics of those with TB-related death and non-TB-related death and controls

From: Tuberculosis mortality: patient characteristics and causes

 

TB-related death (n = 43)

Non-TB-related death (n = 206)

Control (n = 498)

p value

Age (years): mean

75

74

72

0.55

Male (%)

27 (62.8)

153 (74.3)

362 (72.7)

0.31

AFB smear-positive sputum (%)

12 (27.9)

49 (19.4)

99 (19.9)

0.43

Extrapulmonary involvement

25 (58.1)

41 (19.9)

132 (26.5)

<0.001

 TB pleurisy or peritonitis

10 (23.3)

28 (13.6)

54 (10.8)

0.05

 TB lymphadenitis

0

1 (0.5)

6 (1.2)

0.54

 Urogenital TB

2 (4.7)

2 (1)

4 (0.8)

0.06

 Disseminated TB

13 (30.2)

5 (2.4)

34 (6.8)

<0.001

  with meningitis

3

0

6

 

  without meningitis

10

5

28

 

 Gastrointestinal TB

0

3 (1.5)

2 (0.4)

0.25

 Musculoskeletal TB

0

2 (1)

26 (5.2)

0.01

 TB meningitis

0

0

6 (1.2)

0.22

Hemoglobin (g/dl): mean

10.6

11.7

11.4

0.001

Comorbidity (%)

23 (53.5)

162 (78.6)

184 (36.9)

<0.001

 Malignancy

9 (20.9)

114 (55.3)

61 (12.2)

<0.001

 Diabetes mellitus

10 (23.3)

55 (26.7)

117 (23.5)

0.66

 Liver cirrhosis

6 (14)

25 (12.1)

7 (1.4)

<0.001

 Renal failure

4 (9.3)

24 (11.7)

15 (3.0)

<0.001

HIV/AIDS (%)

2 (4.7)

2 (1.0)

9 (1.8)

0.24

MDRTB (%)

0

5 (2.4)

13 (2.6)

0.57

Radiographic pattern

    

 Pneumonic patch

31 (72.1)

142 (68.9)

210 (42.2)

<0.001

 Miliary shadow

4 (9.3)

6 (2.9)

24 (4.8)

0.17

 Cavity

4 (9.3)

9 (4.4)

58 (11.6)

0.01

 Other pattern

0

36 (17.5)

184 (36.9)

<0.001

 No parenchymal lesion

4(9.3)

13 (6.3)

22 (4.4)

0.28

Delay in treatment >14 days

23 (53.5)

109 (52.9)

228 (45.8)

0.18

  1. AFB: acid-fast bacilli; HIV: human immunodeficiency virus; AIDS: acquired immunodeficiency syndrome; MDR: multidrug resistant; TB: tuberculosis.
  2. Data were percentages unless otherwise described.
  3. p-value for comparisons between mortality cases and survivors.